- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 29/02 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Patent holdings for IPC class A61P 29/02
Total number of patents in this class: 540
10-year publication summary
|
12
|
17
|
6
|
22
|
53
|
61
|
66
|
61
|
37
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centrexion Therapeutics Corporation | 64 |
12 |
| Toray Industries, Inc. | 6652 |
10 |
| Allergan, Inc. | 2600 |
9 |
| Zoetis Services LLC | 1537 |
9 |
| Centre National de La Recherche Scientifique | 9632 |
8 |
| Pfizer Inc. | 3322 |
7 |
| Bayer HealthCare LLC | 1415 |
6 |
| Amgen Inc. | 3779 |
6 |
| Bristol-myers Squibb Company | 5080 |
5 |
| Asahi Kasei Pharma Corporation | 144 |
5 |
| Grünenthal GmbH | 625 |
5 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
5 |
| Ipsen Biopharm Limited | 263 |
5 |
| LTS Lohmann Therapie-Systeme AG | 691 |
5 |
| Mochida Pharmaceutical Co., Ltd. | 334 |
5 |
| Shionogi & Co., Ltd. | 914 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
5 |
| DSM IP Assets B.V. | 5856 |
4 |
| Astellas Pharma Inc. | 1145 |
4 |
| Laboratorios Del Dr. Esteve, S.A. | 239 |
4 |
| Other owners | 416 |